Andrey A Ivanov

7PUBLICATIONS
26CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersSoftware quality, processes and metricsData mining and knowledge discovery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 05, 2025
Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease.

Maylynn Hu, Andrew Li, Payton Fleming

|Oct 08, 2025
Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling.

Jung Seok Hwang, JiHoon Kang, Jaehyun Kim

|Mar 08, 2025
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer.

Changfa Shu, Jianfeng Li, Jin Rui

|Feb 13, 2025
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer.

Guojing Zhang, Abbe Pannucci, Andrey A Ivanov

|Jul 27, 2024
Best practices to evaluate the impact of biomedical research software-metric collection beyond citations.

Awan Afiaz, Andrey A Ivanov, John Chamberlin

|Jan 22, 2021
Online informatics resources to facilitate cancer target and chemical probe discovery.

Xuan Yang, Haian Fu, Andrey A Ivanov

Pageof 2

Frequent Collaborators

2 joint publications

Haian Fu

2 joint publications

Suresh S Ramalingam

1 joint publications

Awan Afiaz

1 joint publications

Sarthak Pati